OI inhibited mRNA expression and production of TNF-α, IL-1β, and IL-6 and NFκB activation in PBMCs, and LPS-activated THP-1 cells from SLE patients, and these effects were dependent on Nrf2 [111]. Here, IL1B is linked to systemic lupus erythematosus.